BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27122868)

  • 21. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation.
    Généreux P; Giustino G; Redfors B; Palmerini T; Witzenbichler B; Weisz G; Stuckey TD; Maehara A; Mehran R; Kirtane AJ; Stone GW
    Int J Cardiol; 2018 Oct; 268():61-67. PubMed ID: 30041804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents.
    Kim SH; Kim EJ; Suh SY; Choi CU; Kim JW; Rha SW; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2007 Sep; 120(3):423-5. PubMed ID: 17097164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
    Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
    Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Stent Thrombosis Post-Percutaneous Coronary Intervention and Associated Rare Complications.
    Fadah K; Patel D; Mishra K; Makhija R; Siddiqui T
    Cureus; 2021 Sep; 13(9):e18370. PubMed ID: 34692363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute multi-vessel coronary stent thrombosis.
    Lawrence MW; Matteucci MJ; Carter LI; Shepherd MS
    J Emerg Med; 2011 Sep; 41(3):e43-8. PubMed ID: 18823736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report.
    Shibutani H; Akita Y; Matsui Y; Yoshinaga M; Karakawa M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):236. PubMed ID: 27887648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents.
    Le Feuvre C; Helft G; Cohen S; Batisse JP; Barthélémy O; Collet JP; Beygui F; Choussat R; Montalescot G; Metzger JP
    Arch Cardiovasc Dis; 2008 Apr; 101(4):220-5. PubMed ID: 18654096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous subacute thrombosis in bare metal stents implanted into right coronary artery and left anterior descending artery without coexistence of resistance to antiplatelet therapy].
    Frynas K; Krecki R; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2010 Sep; 68(9):1070-3; discussion 1074-5. PubMed ID: 20859908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation.
    Eshtehardi P; Eslami M; Moayed DA
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):410-3. PubMed ID: 18334899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early double stent thrombosis associated with clopidogrel hyporesponsivenesss.
    Rademakers LM; Dewilde W; van de Kerkhof D
    Neth Heart J; 2012 Jan; 20(1):38-41. PubMed ID: 21604104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
    Gibson CM; Karmpaliotis D; Kosmidou I; Murphy SA; Kirtane AJ; Budiu D; Ray KK; Herrmann HC; Lakkis N; Kovach R; French W; Blankenship J; Lui HH; Palabrica T; Jennings LK; Cohen DJ; Morrow DA;
    Am J Cardiol; 2006 May; 97(10):1473-7. PubMed ID: 16679086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Philip F; Stewart S; Southard JA
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):38-48. PubMed ID: 26916633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.